Palliative radiation therapy for superior vena cava syndrome in metastatic Wilms tumor using 10XFFF and 3D surface imaging to avoid anesthesia in a pediatric patient—a teaching case Jean-Claude M. Rwigema, MD, Kelly Lamiman, BS, Robert S. Reznik, MD, Nicole J.H. Lee, BA, Arthur Olch, PhD, Kenneth K. Wong, MD Advances in Radiation Oncology Volume 2, Issue 1, Pages 101-104 (January 2017) DOI: 10.1016/j.adro.2016.12.007 Copyright © 2017 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions
Figure 1 Timeline of patient history and medical interventions. DD4A, vincristine, doxorubicin, dactinomycin; ICE, ifosfamide, carboplatin, etoposide; VITB, vinblastine, irinotecan, temozolomide, bevacizumab; VIT, vinblastine, irinotecan, temozolomide. Advances in Radiation Oncology 2017 2, 101-104DOI: (10.1016/j.adro.2016.12.007) Copyright © 2017 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions
Figure 2 Paired axial and sagittal computed tomography chest scans showing the anterior mediastinal mass 1 week before radiation therapy (A), at the time of computed tomography simulation (B), and 4 weeks after radiation therapy (C). Advances in Radiation Oncology 2017 2, 101-104DOI: (10.1016/j.adro.2016.12.007) Copyright © 2017 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions
Figure 3 Isodose lines displayed on axial computed tomography simulation image. Advances in Radiation Oncology 2017 2, 101-104DOI: (10.1016/j.adro.2016.12.007) Copyright © 2017 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions